Immunomedics Inc. said that it has filed for a 2 million-shareoffering of common stock, the company's second offering in sixmonths.
In July, the Warren, N.J., company raised $15.4 million throughthe sale of 2.2 million shares priced at $7. The stock(NASDAQ:IMMU) closed Friday at $9.63, up 88 cents.
Immunomedics is developing monoclonal antibodies to deliverradioisotopes, chemotherapeutic agents or toxins to detect andtreat cancers and infectious diseases.
If the offering is completed, Immunomedics will have 27.8million shares outstanding. Underwriters Allen & Co. Inc.,Kemper Securities Group Inc. and SBCI Swiss Bank CorporationInvestment Banking Inc. have a 300,000-share overallotmentoption.
(c) 1997 American Health Consultants. All rights reserved.